FDA Clearance Tracker · P960013
TENDRIL DX MODEL 1388T & 1388K ENDOCARDIAL PACING LEADS
Last checked: Nov 20, 2026Latest source record: Jun 20, 1997 (this decision)Source: openFDAMethods & limitations
Decided
Jun 20, 1997
Approved
Time to decision
406 days
Received May 10, 1996. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P960013
- Device name
- TENDRIL DX MODEL 1388T & 1388K ENDOCARDIAL PACING LEADS
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- May 10, 1996
- Decided
- Jun 20, 1997
- Decision
- Approved
- Supplements
- 130 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE TENDRIL(R) DX MODELS 388T/K ENDOCARDIAL, STEROID ELUTING, SCREW-IN PACING LEADS AND VENTRITEX ASSURE(TM) AFS MODELS 7010T/K ENDOCARDIAL, STERIOID ELUTING SCREW-IN PACING LEADS. THESE DEVICES ARE INDICATED FOR USE IN COMBINATION IWTH A COMPATIBLE PULSE GENERATOR TO PROVIDE PERMANENT PACING AND SENSING IN EITHER THE ATRIUM OR VENTRICLE.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NVN. The earliest in FDA's data is P850089, decided Jul 29, 1986.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
- EnSite X EP System510(k)
K261729 · Decided Sep 17, 2026 · 114 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
- TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDMPMA supplement
P220013-S028 · Decided Sep 4, 2026 · 186 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.